Otsuka Holdings (4578) Stock Overview
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
4578 Community Fair Values
See what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Otsuka Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8,332.00 |
| 52 Week High | JP¥9,211.00 |
| 52 Week Low | JP¥6,465.00 |
| Beta | -0.13 |
| 1 Month Change | 1.26% |
| 3 Month Change | 3.30% |
| 1 Year Change | -6.93% |
| 3 Year Change | 75.08% |
| 5 Year Change | 89.71% |
| Change since IPO | 289.35% |
Recent News & Updates
Otsuka Holdings (TSE:4578) Is Due To Pay A Dividend Of ¥70.00
Nov 14Otsuka Holdings (TSE:4578) Is Due To Pay A Dividend Of ¥70.00
Oct 31Recent updates
Shareholder Returns
| 4578 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.6% | 2.5% | -3.3% |
| 1Y | -6.9% | 7.0% | 19.6% |
Return vs Industry: 4578 underperformed the JP Pharmaceuticals industry which returned 7% over the past year.
Return vs Market: 4578 underperformed the JP Market which returned 19.6% over the past year.
Price Volatility
| 4578 volatility | |
|---|---|
| 4578 Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4578 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4578's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | 35,338 | Makoto Inoue | www.otsuka.com |
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts.
Otsuka Holdings Co., Ltd. Fundamentals Summary
| 4578 fundamental statistics | |
|---|---|
| Market cap | JP¥4.40t |
| Earnings (TTM) | JP¥449.11b |
| Revenue (TTM) | JP¥2.42t |
Is 4578 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4578 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.42t |
| Cost of Revenue | JP¥684.07b |
| Gross Profit | JP¥1.73t |
| Other Expenses | JP¥1.29t |
| Earnings | JP¥449.11b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 13, 2026
| Earnings per share (EPS) | 850.37 |
| Gross Margin | 71.72% |
| Net Profit Margin | 18.57% |
| Debt/Equity Ratio | 4.2% |
How did 4578 perform over the long term?
See historical performance and comparisonDividends
Does 4578 pay a reliable dividends?
See 4578 dividend history and benchmarks| Otsuka Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Dec 29 2025 |
| Dividend Pay Date | Mar 31 2026 |
| Days until Ex dividend | 38 days |
| Days until Dividend pay date | 130 days |
Does 4578 pay a reliable dividends?
See 4578 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/20 17:48 |
| End of Day Share Price | 2025/11/20 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Otsuka Holdings Co., Ltd. is covered by 19 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Koichi Mamegano | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |



